NCT07113847

Brief Summary

84 patients who fulfill the inclusion criteria will be enrolled to the study. For every patient a tooth of complain which fulfill the inclusion criteria will be selected, so the total number of included teeth will be 84 teeth. Teeth will be classified into 4 groups according to the type of desensitizer used. Where in group 1 (G1) patients will be randomly assigned to "Resin-Based Desensitizer", in group 2 (G2) patients will be randomly assigned to "Laser Desensitizer", in group 3 (G3) patients will be randomly assigned to "Combination of Laser + Resin-Based Desensitizer", and in group 4 (G4) patients will be randomly assigned to "Fluoride-Based Desensitizer". For every patient, sensitivity test will be done using visual analogue scale immediately after application, three months after application and six months after application. Table 1 shows the variables of the study, and Table 2 shows the variables of the study. Each patient's name will be replaced with a case number within the group to protect the privacy of medical information and data of the patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Apr 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

August 3, 2025

Last Update Submit

August 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual analogue scale (VAS)

    post-operative hypersensitivity assessment with the visual analogue scale from 0-10 with 0 is the minimum sensitivity record and 10 is the maximum sensitivity record

    0,3,6 months

Study Arms (4)

Resin-Based Desensitizer

ACTIVE COMPARATOR
Biological: Resin-Based Desensitizer

Laser Desensitizer

ACTIVE COMPARATOR
Device: Laser Desensitizer

Combination of Laser + Resin-Based Desensitizer

ACTIVE COMPARATOR
Biological: Resin-Based DesensitizerDevice: Laser Desensitizer

Fluoride-Based Desensitizer

ACTIVE COMPARATOR
Biological: Fluoride-Based Desensitizer

Interventions

resin desensitizing agent

Combination of Laser + Resin-Based DesensitizerResin-Based Desensitizer

Low-power Diode laser

Combination of Laser + Resin-Based DesensitizerLaser Desensitizer

Fluoride-based varnish

Fluoride-Based Desensitizer

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males or Females
  • years.
  • Not received antibiotic therapy for 1 month before sampling.
  • Good oral hygiene.
  • Co-operative patients approving the trial.
  • Compliant patients.

You may not qualify if:

  • Pregnancy.
  • Systemic disease or severe medical complications.
  • Patients who did any periodontal surgeries within the previous 6 months.
  • Patients with bad oral hygiene.
  • Patients who are allergic to any ingredients used in the study.
  • Xerostomia.
  • Lack of compliance.
  • Non carious lesions.
  • Cervical lesions.
  • Teeth with DH, VAS \>5.
  • Carious teeth.
  • Chipped teeth.
  • Teeth with mobility Grade 2 or 3.
  • Teeth with probing depth more than 4 mm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BUE

Cairo, El Shorouk City, Egypt

Location

MeSH Terms

Conditions

Dentin Sensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 84 patients who fulfill the inclusion criteria will be enrolled to the study. For every patient a tooth of complain which fulfill the inclusion criteria will be selected, so the total number of included teeth will be 84 teeth. Teeth will be classified into 4 groups according to the type of desensitizer used. Where in group 1 (G1) patients will be randomly assigned to "Resin-Based Desensitizer", in group 2 (G2) patients will be randomly assigned to "Laser Desensitizer", in group 3 (G3) patients will be randomly assigned to "Combination of Laser + Resin-Based Desensitizer", and in group 4 (G4) patients will be randomly assigned to "Fluoride-Based Desensitizer". For every patient, sensitivity test will be done using visual analogue scale immediately after application, three months after application and six months after application. Table 1 shows the variables of the study,
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Demonstrator

Study Record Dates

First Submitted

August 3, 2025

First Posted

August 11, 2025

Study Start

April 1, 2025

Primary Completion

October 1, 2025

Study Completion

October 30, 2025

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All Data are available upon request

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
1 year

Locations